Cannot help but wonder to the veracity of Pfizer's announcement and the crazy market reaction. Whilst the news is undoubtedly good, there may have been a massive over-reaction to it (US SP500 was 4%+ overnight. MSB was -10% in US trading (basically around $3 AUD). My concerns regards Pfizer's results are that the data appears very premature. Here is the actual release (rather than the media crap and patchy CEO comment):
https://investors.pfizer.com/investor-news/press-release-details/2020/Pfizer-and-BioNTech-Announce-Vaccine-Candidate-Against-COVID-19-Achieved-Success-in-First-Interim-Analysis-from-Phase-3-Study/default.aspx
"The case split between vaccinated individuals and those who received the placebo indicates a vaccine efficacy rate above 90%, at 7 days after the second dose".
At initial observation, a 7 day endpoint is far too premature to be dancing a jig. Hopefully the efficacy rates continue, but it seems a little unprofessional to be touting this as "a great day for humanity" at such an early endpoint result. The trial had reported seen 39K patients receive second doses as of 8 November.
Protocol is here:
https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-11/C4591001_Clinical_Protocol_Nov2020.pdf
Alas MSB stock will be taking a big hit today on this. Mt Sinai have been far to slow in trialling and the door is closing in the eyes of the mkts at least.
Pfizer announcement
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.045(3.83%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.19 | $1.12 | $7.839M | 6.868M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 157745 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 48625 | 15 |
View Market Depth
| Last trade - 13.15pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.13 |
Change
-0.045 ( 4.33 %) |
||||
| Open | High | Low | Volume | ||
| $1.17 | $1.17 | $1.12 | 841107 | ||
| Last updated 13.32pm 08/05/2024 ? | |||||
| MSB (ASX) Chart |